<bill session="109" type="s" number="1893" updated="2013-07-19T20:29:58-04:00">
  <state datetime="2005-10-19">REFERRED</state>
  <status>
    <introduced datetime="2005-10-19"/>
  </status>
  <introduced datetime="2005-10-19"/>
  <titles>
    <title as="introduced" type="short">Biotechnology Future Investment Expansion Act of 2005</title>
    <title as="introduced" type="official">A bill to permit biomedical research corporations to engage in certain financings and other transactions without incurring limitations on net operating loss carryforwards and certain built-in losses, and for other purposes.</title>
  </titles>
  <sponsor id="300085"/>
  <cosponsors/>
  <actions>
    <action datetime="2005-10-19">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S11567"/>
    </action>
    <action state="REFERRED" datetime="2005-10-19">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S11567-11568" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="109" type="h" number="4082"/>
  </relatedbills>
  <subjects>
    <term name="Taxation"/>
    <term name="Accounting"/>
    <term name="Biotechnology"/>
    <term name="Capital gains tax"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Corporate debt"/>
    <term name="Corporate finance"/>
    <term name="Corporate mergers"/>
    <term name="Corporate reorganizations"/>
    <term name="Corporation taxes"/>
    <term name="Drug industry"/>
    <term name="Finance and financial sector"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Investments"/>
    <term name="Losses"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
    <term name="Tax credits"/>
    <term name="Tax exclusion"/>
    <term name="Tax incentives"/>
  </subjects>
  <amendments/>
  <summary>10/19/2005--Introduced.
Biotechnology Future Investment Expansion Act of 2005 - Amends the Internal Revenue Code to permit certain biomedical research corporations to engage in investments and other transactions involving shifts in ownership without incurring limitations on net operating loss carryforwards and certain built-in losses.</summary>
</bill>
